• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫情期间的心内科团队:一例经瓣中瓣植入治疗生物假体退化的病例报告

The Heart Team during the Pandemic: A Case Report of Bio-Prosthesis Degeneration Treated with Valve in Valve Implantation.

作者信息

Manes Maria Teresa, Ritacco Anna Rita, Cassano Susanna, Ferrò Maria Teresa, Manduca Bruno, Spaccarotella Carmen, Musacchio Domenico

机构信息

Department of Cardiology, Paola-Cetraro Hospital, Paola CS, Italy.

Department of Hemodynamics, University Magna Grecia, Catanzaro CZ, Italy.

出版信息

J Cardiovasc Echogr. 2024 Apr-Jun;34(2):77-81. doi: 10.4103/jcecho.jcecho_12_23. Epub 2024 Jun 28.

DOI:10.4103/jcecho.jcecho_12_23
PMID:39086702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11288296/
Abstract

The pandemic changed the type of patients. The concept of "patient at the center" became concrete. The execution of simple consultancy was overcome to create effective collaboration and fruitful exchanges between specialists. The "Heart Team" model is on increasing affirmation. The TEAM-BASED approach in the cardiology field is successfully used in patients suffering from ischemic heart disease and valvulopathies for the choice of possible treatments. Degenerative type Sao is the most frequent valvulopathy among the valvulopathies in Western countries and its incidence is correlated with age. In high-risk patients, percutaneous valve replacement (transcatheter aortic valve implantation) is the most valid therapeutic option. The implantation of biological prostheses raises the problem of both degeneration and dysfunction of the prosthesis itself over time in subjects of advanced age and with comorbidities. In this scenario, valve-in-valve (VinV) is a valid therapeutic alternative in high-risk patients. A clinical case of aortic prosthetic degeneration, as an outcome of endocarditis, treated with VinV is presented. The therapeutic decision was made by an "Electronic Heart Team" which represents a further evolution of the treatment pathways and reduces the distance between the specialists in "Hub" Centers and the "Spoke" center.

摘要

疫情改变了患者类型。“以患者为中心”的理念变得具体起来。克服了简单咨询的做法,以在专家之间建立有效的合作和富有成效的交流。“心脏团队”模式越来越得到认可。心脏病领域基于团队的方法已成功应用于患有缺血性心脏病和瓣膜病的患者,以选择可能的治疗方案。退行性瓣膜病是西方国家瓣膜病中最常见的类型,其发病率与年龄相关。在高危患者中,经皮瓣膜置换术(经导管主动脉瓣植入术)是最有效的治疗选择。生物假体的植入随着时间的推移在老年和患有合并症的患者中引发了假体本身退化和功能障碍的问题。在这种情况下,瓣中瓣(VinV)是高危患者的一种有效治疗选择。本文介绍了一例因心内膜炎导致主动脉假体退化并采用VinV治疗的临床病例。治疗决策由一个“电子心脏团队”做出,该团队代表了治疗途径的进一步发展,并缩短了“枢纽”中心和“辐条”中心的专家之间的距离。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/e9b6bb6df796/JCE-34-77-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/0527e17eefe1/JCE-34-77-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/726a133b3494/JCE-34-77-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/9174500156f7/JCE-34-77-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/b00da6868c21/JCE-34-77-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/e9b6bb6df796/JCE-34-77-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/0527e17eefe1/JCE-34-77-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/726a133b3494/JCE-34-77-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/9174500156f7/JCE-34-77-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/b00da6868c21/JCE-34-77-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194e/11288296/e9b6bb6df796/JCE-34-77-g005.jpg

相似文献

1
The Heart Team during the Pandemic: A Case Report of Bio-Prosthesis Degeneration Treated with Valve in Valve Implantation.疫情期间的心内科团队:一例经瓣中瓣植入治疗生物假体退化的病例报告
J Cardiovasc Echogr. 2024 Apr-Jun;34(2):77-81. doi: 10.4103/jcecho.jcecho_12_23. Epub 2024 Jun 28.
2
Treatment of failed aortic bioprostheses: An evaluation of conventional redo surgery and transfemoral transcatheter aortic valve-in-valve implantation.主动脉生物瓣衰败的治疗:传统再次开胸手术与经股动脉经导管主动脉瓣瓣中瓣植入术的评估。
Int J Cardiol. 2020 Feb 1;300:80-86. doi: 10.1016/j.ijcard.2019.09.039. Epub 2019 Oct 31.
3
Transcatheter Aortic and Mitral Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves: An 8-Year Single-Center Experience.经导管主动脉瓣和二尖瓣瓣中瓣植入治疗失败的外科生物瓣:一项 8 年单中心经验。
JACC Cardiovasc Interv. 2015 Nov;8(13):1735-44. doi: 10.1016/j.jcin.2015.08.012. Epub 2015 Oct 14.
4
Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.北欧国家经导管主动脉瓣中瓣植入术的早期临床结果。
J Thorac Cardiovasc Surg. 2013 Nov;146(5):1047-54; discussion 1054. doi: 10.1016/j.jtcvs.2013.06.045. Epub 2013 Aug 30.
5
Transapical aortic valve implantation in patients with pre-existing mitral valve prostheses: a case report.既往有二尖瓣人工瓣膜患者的经心尖主动脉瓣植入术:一例报告
J Cardiothorac Surg. 2016 Aug 8;11(1):133. doi: 10.1186/s13019-016-0521-0.
6
Transapical aortic 'valve-in-valve' procedure for degenerated stented bioprosthesis.经导管主动脉瓣瓣中瓣手术治疗退行性支架生物瓣。
Eur J Cardiothorac Surg. 2012 Mar;41(3):485-90. doi: 10.1093/ejcts/ezr027. Epub 2011 Oct 18.
7
My rules of a perfect SAPIEN™ transcatheter aortic valve implantation.我关于完美的SAPIEN™经导管主动脉瓣植入术的规则。
Minerva Cardioangiol. 2012 Feb;60(1):71-83.
8
[Transapical transcatheter aortic valve replacement for high risk pure non-calcified aortic regurgitation: two years outcome of a multi-center study].经心尖经导管主动脉瓣置换术治疗高危单纯非钙化性主动脉瓣反流:一项多中心研究的两年结果
Zhonghua Wai Ke Za Zhi. 2018 Dec 1;56(12):910-915. doi: 10.3760/cma.j.issn.0529-5815.2018.12.007.
9
Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves.经导管瓣膜内植入术(VinV-TAVR)治疗失败的外科生物瓣主动脉瓣。
Clin Res Cardiol. 2019 Jan;108(1):83-92. doi: 10.1007/s00392-018-1326-z. Epub 2018 Jul 12.
10
Transapical aortic valve-in-valve-in-valve implantation as a procedural rescue option.经心尖主动脉瓣中瓣中瓣植入术作为一种程序性抢救方案。
Ann Thorac Surg. 2013 Jan;95(1):325-8. doi: 10.1016/j.athoracsur.2012.05.063. Epub 2012 Dec 25.

本文引用的文献

1
[Heart Team and heart valve diseases: the importance of a multidisciplinary approach].[心脏团队与心脏瓣膜疾病:多学科方法的重要性]
G Ital Cardiol (Rome). 2021 Jul;22(7):561-569. doi: 10.1714/3629.36107.
2
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
3
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.经导管主动脉瓣置换术治疗失败的外科生物瓣患者的 1 年结果。
JACC Cardiovasc Interv. 2017 May 22;10(10):1034-1044. doi: 10.1016/j.jcin.2017.03.018.
4
Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry.经导管主动脉瓣植入术在退行性主动脉外科生物瓣中的应用:PARTNER 2 瓣中瓣注册研究。
J Am Coll Cardiol. 2017 May 9;69(18):2253-2262. doi: 10.1016/j.jacc.2017.02.057.
5
[ANMCO/SIC/SICI-GISE/SICCH Consensus document: Risk stratification in elderly patients undergoing cardiac surgery and transcatheter aortic valve implantation].[ANMCO/SIC/SICI-GISE/SICCH共识文件:心脏手术和经导管主动脉瓣植入老年患者的风险分层]
G Ital Cardiol (Rome). 2016 Sep;17(9):756-789. doi: 10.1714/2448.25664.
6
[2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)].[2015年欧洲心脏病学会(ESC)感染性心内膜炎管理指南。欧洲心脏病学会(ESC)感染性心内膜炎管理工作组]
G Ital Cardiol (Rome). 2016 Apr;17(4):277-319. doi: 10.1714/2214.23904.
7
[Valve-in-valve with Portico valve for a degenerative bioprosthetic surgical valve (Biocor)].使用Portico瓣膜进行瓣中瓣手术治疗退行性生物人工心脏瓣膜(Biocor)
G Ital Cardiol (Rome). 2016 Apr;17(4):273-6. doi: 10.1714/2214.23902.
8
Transcatheter aortic valve-in-valve implantation for patients with degenerative surgical bioprosthetic valves.经导管主动脉瓣中瓣植入术治疗退行性外科生物瓣膜患者。
Circ J. 2015;79(4):695-703. doi: 10.1253/circj.CJ-14-1418. Epub 2015 Mar 20.
9
Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.经导管主动脉瓣植入术治疗失败的生物瓣。
JAMA. 2014 Jul;312(2):162-70. doi: 10.1001/jama.2014.7246.
10
[TAVI in degenerative aortic stenosis treatment: state of the art and future perspectives].[经导管主动脉瓣植入术治疗退行性主动脉瓣狭窄:现状与未来展望]
Recenti Prog Med. 2014 Feb;105(2):63-7. doi: 10.1701/1417.15698.